Clinical Outcomes of Gemcitabine Plus Nab-Paclitaxel-Based Chemoradiotherapy in a Multidisciplinary Treatment Strategy for Locally Advanced Pancreatic Cancer (NUPAT-05): A Prospective, Single-Arm, Phase II Study.

Yamada H, Tanaka H, Yamada S, Takami H, Hayashi M, Nakagawa N, Kurimoto K, Inokawa Y, Watanabe N, Ishikawa T, Okumura M, Ogawa H, Ando M, Maeda O, Yamaguchi J, Naganawa S, Kawashima H, Fujii T, Yokoyama Y, Ebata T, Kanda M

Open source

DOI: 10.1002/ijc.70801
Published: 2026 Oct 22
Container: International journal of cancer
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ijc.70801,
  title = {Clinical Outcomes of Gemcitabine Plus Nab-Paclitaxel-Based Chemoradiotherapy in a Multidisciplinary Treatment Strategy for Locally Advanced Pancreatic Cancer (NUPAT-05): A Prospective, Single-Arm, Phase II Study.},
  author = {Yamada H and Tanaka H and Yamada S and Takami H and Hayashi M and Nakagawa N and Kurimoto K and Inokawa Y and Watanabe N and Ishikawa T and Okumura M and Ogawa H and Ando M and Maeda O and Yamaguchi J and Naganawa S and Kawashima H and Fujii T and Yokoyama Y and Ebata T and Kanda M},
  year = {2026},
  journal = {International journal of cancer},
  doi = {10.1002/ijc.70801},
  url = {https://doi.org/10.1002/ijc.70801}
}

RIS

TY  - JOUR
TI  - Clinical Outcomes of Gemcitabine Plus Nab-Paclitaxel-Based Chemoradiotherapy in a Multidisciplinary Treatment Strategy for Locally Advanced Pancreatic Cancer (NUPAT-05): A Prospective, Single-Arm, Phase II Study.
AU  - Yamada H
AU  - Tanaka H
AU  - Yamada S
AU  - Takami H
AU  - Hayashi M
AU  - Nakagawa N
AU  - Kurimoto K
AU  - Inokawa Y
AU  - Watanabe N
AU  - Ishikawa T
AU  - Okumura M
AU  - Ogawa H
AU  - Ando M
AU  - Maeda O
AU  - Yamaguchi J
AU  - Naganawa S
AU  - Kawashima H
AU  - Fujii T
AU  - Yokoyama Y
AU  - Ebata T
AU  - Kanda M
PY  - 2026
JO  - International journal of cancer
DO  - 10.1002/ijc.70801
UR  - https://doi.org/10.1002/ijc.70801
ER  -

APA

H, Y., H, T., S, Y., H, T., M, H., N, N., K, K., Y, I., N, W., T, I., M, O., H, O., M, A., O, M., J, Y., S, N., H, K., T, F., Y, Y., T, E., & M, K. (2026). Clinical Outcomes of Gemcitabine Plus Nab-Paclitaxel-Based Chemoradiotherapy in a Multidisciplinary Treatment Strategy for Locally Advanced Pancreatic Cancer (NUPAT-05): A Prospective, Single-Arm, Phase II Study.. International journal of cancer. https://doi.org/10.1002/ijc.70801

Source records

pubmed · retrieved 2026-11-10T07:26:49.694Z